News

Galderma lança aplicativo de realidade aumentada para simulação em tempo real de possíveis efeitos de tratamentos estéticos injetáveis

by

FACE by GaldermaTM está em sua primeira fase de lançamento e já traz dados surpreendentes: 72% dos pacientes que usaram a tecnologia agendaram um procedimento estético injetável após o uso do aplicativo SÃO PAULO, 21 de junho de 2023 /PRNewswire/ — A Galderma, especialista em soluções para cuidados com a pele, que abrange medicamentos de prescrição médica, dermocosméticos … Read more

Non-insulin Diabetes Therapeutics Market size is set to grow by USD 31,251.55 million from 2022-2027; Increasing number of people with Type 2 diabetes will boost the market- Technavio

by

NEW YORK, June 21, 2023 /PRNewswire/ — The global non-insulin diabetes therapeutics market size is estimated to grow by USD 31,251.55 million from 2022 to 2027. The market is estimated to grow at a CAGR of 10.82%. However, the growth momentum will progress during the forecast period. North America held the largest share of the global market in … Read more

INTERNATIONAL ISOTOPES INC. ANNOUNCES THE ACQUISITION OF THE AMICI INC. PRODUCT LINE

by

The Products Include All Molds, Manufacturing, And Registration Rights To AMICI’s Leading Products, Including The “Swirler”, “UltraShield”, and “Tru-Fit” Mouth Piece IDAHO FALLS, Idaho, June 21, 2023 /PRNewswire/ — International Isotopes Inc. (OTCQB: INIS) (“International Isotopes,” “INIS” or the “Company”) is pleased to announce that it has acquired the manufacturing molds, device registrations, trademarks, and all production … Read more

New research highlights a significant and continued gap in achieving diversity in clinical trials of medical therapies

by

Clario and Tufts Center for the Study of Drug Development (CSDD) to present new results at the DIA 2023 Annual Global Meeting showing a sustained under-representation of minority communities in pivotal trials supporting new drug and biologic approvals. Data from 1,165 pivotal trials for 550 NDAs and BLAs were collected (FDA approvals 2007 – 2021) … Read more

New research highlights a significant and continued gap in achieving diversity in clinical trials of medical therapies

by

Clario and Tufts Center for the Study of Drug Development (CSDD) to present new results at the DIA 2023 Annual Global Meeting showing a sustained under-representation of minority communities in pivotal trials supporting new drug and biologic approvals. Data from 1,165 pivotal trials for 550 NDAs and BLAs were collected (FDA approvals 2007 – 2021) … Read more

Canopy Growth to Report Fourth Quarter and Fiscal Year 2023 Financial Results on June 22, 2023

by

SMITHS FALLS, ON, June 21, 2023 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the fourth quarter and fiscal year 2023 ended March 31, 2023, and file the Company’s comprehensive annual report on Form 10-K for the fiscal years ended March 31, 2023 … Read more

Healthcare-Focused Private Equity Manager Martis Capital Secures Investment From Kudu Investment Management

by

NEW YORK and SAN FRANCISCO and WASHINGTON, June 21, 2023 /PRNewswire/ — Martis Capital Management, LLC (Martis Capital), a healthcare-focused private equity firm, and Kudu Investment Management, LLC (Kudu), a provider of permanent capital solutions to independent asset and wealth managers worldwide, today announced that Kudu has made a minority investment in Martis Capital. Financial … Read more

Liquid I.V. Unveils Innovative Hydration Multiplier Sugar-Free Product

by

As the first and only allulose and amino acid blend on the market, Liquid I.V.’s Sugar-Free hydration drink mix offers consumers enhanced product benefits in the wellness category LOS ANGELES, June 21, 2023 /PRNewswire/ — Liquid I.V., the number one powdered hydration company in the U.S., today announced an exclusive expansion of their product portfolio … Read more

Intrinsic Therapeutics, Inc. Announces Positive Coverage Policy by Cigna Healthcare for Barricaid Bone-Anchored Annular Closure Device

by

BOSTON, June 21, 2023 /PRNewswire/ — Intrinsic Therapeutics, Inc., a medical device company focused on preventing reherniation and reoperation following lumbar discectomy, announced today that Cigna Healthcare has issued a positive coverage policy for the Barricaid® Bone-Anchored Annular Closure device. Cigna Healthcare represents one of the five largest commercial payors in the US, with an estimated … Read more

The American Healthcare Documentation Professionals Group Announces Augusta Technical College, Morehouse School of Medicine, and MedCerts as First Programs to Meet Requirements for Medical Scribe Training Program Approval

by

SHREWSBURY, Mass., June 21, 2023 /PRNewswire/ — The American Healthcare Documentation Professionals Group (AHDPG), a leader in healthcare training, certification, and services, is thrilled to announce the launch of our latest offering: Medical Scribe Training Program Approval. The goal of this program is to elevate the level of scribe training available and become an industry … Read more